fashion -WSS

fashion

author：comprehensive 2025-09-06 04:30:10 - browse：9

Adam's take main illustration — Molly Ferguson/STAT

Have you heard the news? I’m launching a weekly email newsletter starting on March 28. It’s called Adam’s Biotech Scorecard and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week? Unfiltered, uncompromising, and (hopefully) valuable insight and analysis from the intersection of Wall Street and biotech. Plus, a few dashes of fun.

This week: A chat with Argenx CEO Tim Van Hauwermeiren, and updates on biotech PIPEs, Madrigal Pharmaceuticals, and Annovis Bio.

The Belgian drugmaker Argenx is preparing for a commercial launch this summer that will expand the use of its IgG-lowering antibody Vyvgart to patients with chronic inflammatory demyelinating polyneuropathy, or CIDP, an autoimmune nerve disorder that causes people to lose feeling and muscle strength in the arms and legs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Medicare to cover more brain scans related to Alzheimer’s drugs

WSS

Eight reasons why you should get an updated Covid vaccine

What's changing in Medicare's open enrollment this year?

Why patients can’t get everything they want on drug pricing

Massive project maps cells in human brain in unprecedented detail

Massive project maps cells in human brain in unprecedented detail

Biden warns of ‘dark winter’ during final presidental debate

hotspot

fashion

focus

How one medical school became remarkably diverse

Researchers CRISPR chickens in bid to protect them from bird flu

How to save PrEP access — and even expand it

How clinical AI models' predictive power can degrade over time

Hollywood unions extend contract negotiations for actors

There’s no way to know how good AI health technologies are

Hollywood unions extend contract negotiations for actors

Device maker Teleflex to acquire urology company for $600M

How to save PrEP access — and even expand it

Nick Jonas talks about managing diabetes along with his career

focus

There’s no way to know how good AI health technologies are

Humana CEO Bruce Broussard to step down in 2024

STAT Readout: Today's biotech news includes Sana and Amylyx

A new crop of companies is reshaping the health data economy

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

Wellcome Trust names Røttingen as its new CEO

focus

leisure time

focus

focus